Perflow Medical announces first clinical use of Stream17 Dynamic Neurothrombectomy Net

perflow medical stream17 device
Perflow Stream17 device

Perflow Medical has announced the first successful clinical use of its Stream17 Dynamic Neurothrombectomy Net—a lower profile device designed to effectively treat haemorrhagic and ischaemic stroke patients with more tortuous anatomies. The first clinical procedures using the device were completed by Kārlis Kupčs, head of radiology at Pauls Stradiņš Clinical University Hospital in Riga, Latvia.

“We recently brought the Stream family of products into our institution, and I have been very pleased with the additional physician control and positive outcomes when using this next-generation stentriever in my practice,” said Kupčs. “With the Stream17, I appreciate the ability to navigate through a small .017” microcatheter to effectively remove thrombus in more distal vessels. Moreover, the device was easy to use and resulted in efficient, full recanalisation of the vessel.”

According to a press release from Israel-based neurovascular treatment innovator Perflow, the Stream17 Dynamic Neurothrombectomy Net is built on the company’s proprietary CEREBRAL NET technology. The addition of the Stream17 to its portfolio means Perflow now offers “a complete line of stroke products” to perform mechanical thrombectomy from proximal large vessel occlusions up to distal blood clots in the distal M2/M3 segments.

This news builds on the recent announcement detailing the first clinical use of the Cascade17 Non-Occlusive Remodeling Net, which maintains vessel patency during coil embolisation of intracranial aneurysms. The company’s Cascade Net and Stream Net product families are now both commercially available across Europe for the treatment of intracranial aneurysms and acute ischaemic stroke respectively, but have not yet been cleared for clinical use in the USA.

“Our centre is one of the most active in the country for stroke, with a comprehensive range of treatments and consistently excellent clinical results,” said Paul Bhogal, interventional radiologist at Barts Health NHS Trust in London, UK. “As part of that achievement, we believe in the value of adopting promising new tools, such as Perflow’s dynamic-control net devices, and have integrated them into our toolbox. I am especially excited about the Stream17, which enables access to previously unreachable blockages.”


Please enter your comment!
Please enter your name here